1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Necrotizing Soft Tissue Infection: new trials by email Literature Review of Necrotizing Soft Tissue Infection trials Research Report on Necrotizing Soft Tissue Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HAT for the Treatment of Sepsis Associated With NASTI HAT, Placebo - Necrotizing Soft Tissue Infection, Sepsis | Phase 1 / Phase 2 | Terminated | Ascension Health | 10 | 2021-09-10 | 2024-07-24 |
| Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial IVIG (Privigen), Saline 0.9% - Necrotizing Soft Tissue Infection, Necrotizing Fasciitis | Phase 2 | Completed | Anders Perner | 100 | 2014-04-01 | 2016-09-30 |
Fasciitis, Necrotizing (1) · Fournier Gangrene (1) · Gas Gangrene (1) · Sepsis (1)
Infections (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Clostridium Infections (1) · Fasciitis (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Gram-Positive Bacterial Infections (1) · Inflammation (1) · Male Urogenital Diseases (1) · Musculoskeletal Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Systemic Inflammatory Response Syndrome (1) · Urogenital Diseases (1)
Sodium Chloride (2) · Ascorbic Acid (1) · Hydrocortisone (1) · Immunoglobulin G (1) · Immunoglobulins, Intravenous (1) · Thiamine (1)
Anders Perner (1) · Ascension Health (1)
Denmark (1) · United States (1)
Anders Perner, Professor (1) · Thomas Resch, M.D. (1)